A citation-based method for searching scientific literature

Alexandra E Shields. Addict Sci Clin Pract 2011
Times Cited: 9







List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Joel Gelernter, Ralitza Gueorguieva, Henry R Kranzler, Huiping Zhang, Joyce Cramer, Robert Rosenheck, John H Krystal. Alcohol Clin Exp Res 2007
163
33

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
David W Oslin, Wade Berrettini, Henry R Kranzler, Helen Pettinati, Joel Gelernter, Joseph R Volpicelli, Charles P O'Brien. Neuropsychopharmacology 2003
437
33


The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.
Lara A Ray, Christina S Barr, Julie A Blendy, David Oslin, David Goldman, Raymond F Anton. Alcohol Clin Exp Res 2012
63
22


Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
C Bond, K S LaForge, M Tian, D Melia, S Zhang, L Borg, J Gong, J Schluger, J A Strong, S M Leal,[...]. Proc Natl Acad Sci U S A 1998
812
22

Pharmacogenetic approaches to the treatment of alcohol addiction.
Markus Heilig, David Goldman, Wade Berrettini, Charles P O'Brien. Nat Rev Neurosci 2011
161
22

Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking.
Andrea C King, Harriet de Wit, Patrick J McNamara, Dingcai Cao. Arch Gen Psychiatry 2011
243
22

A genetic determinant of the striatal dopamine response to alcohol in men.
V A Ramchandani, J Umhau, F J Pavon, V Ruiz-Velasco, W Margas, H Sun, R Damadzic, R Eskay, M Schoor, A Thorsell,[...]. Mol Psychiatry 2011
216
22

Pharmacogenetics of alcohol and alcohol dependence treatment.
Henry R Kranzler, Howard J Edenberg. Curr Pharm Des 2010
48
22


Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques.
Christina S Barr, Melanie Schwandt, Stephen G Lindell, Scott A Chen, David Goldman, Stephen J Suomi, J Dee Higley, Markus Heilig. Arch Gen Psychiatry 2007
92
22

A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys.
Eric J Vallender, Daniela Rüedi-Bettschen, Gregory M Miller, Donna M Platt. Drug Alcohol Depend 2010
39
22

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.
Antonio-Javier Chamorro, Miguel Marcos, José-Antonio Mirón-Canelo, Isabel Pastor, Rogelio González-Sarmiento, Francisco-Javier Laso. Addict Biol 2012
108
22

Understanding US addiction physicians' low rate of naltrexone prescription.
Tami L Mark, Henry R Kranzler, Xue Song. Drug Alcohol Depend 2003
90
22

Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.
Christina S Barr, Scott A Chen, Melanie L Schwandt, Stephen G Lindell, Hui Sun, Stephen J Suomi, Markus Heilig. Biol Psychiatry 2010
48
22

Attitudes about genetics in underserved, culturally diverse populations.
Diana S Catz, Nancy S Green, Jonathan N Tobin, Michele A Lloyd-Puryear, Penny Kyler, Ann Umemoto, Jennifer Cernoch, Roxane Brown, Fredericka Wolman. Community Genet 2005
109
22

Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics.
Alexandra E Shields, Douglas E Levy, David Blumenthal, Douglas Currivan, Mary McGinn-Shapiro, Kevin B Weiss, Recai Yucel, Caryn Lerman. Nicotine Tob Res 2008
15
22


Racial differences in beliefs about genetic screening among patients at inner-city neighborhood health centers.
Richard K Zimmerman, Melissa Tabbarah, Mary Patricia Nowalk, Mahlon Raymund, Ilene K Jewell, Stephen A Wilson, Edmund M Ricci. J Natl Med Assoc 2006
36
22


Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians.
Alexandra E Shields, David Blumenthal, Kevin B Weiss, Catherine B Comstock, Douglas Currivan, Caryn Lerman. J Gen Intern Med 2005
51
22

Being more realistic about the public health impact of genomic medicine.
Wayne D Hall, Rebecca Mathews, Katherine I Morley. PLoS Med 2010
31
22



The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
A R Shuldiner, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein,[...]. Clin Pharmacol Ther 2013
118
22

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
371
22

Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Dan M Roden, Sara L Van Driest, Jonathan D Mosley, Quinn S Wells, Jamie R Robinson, Joshua C Denny, Josh F Peterson. Clin Pharmacol Ther 2018
47
22


Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
Bankole A Johnson, Nassima Ait-Daoud, Chamindi Seneviratne, John D Roache, Martin A Javors, Xin-Qun Wang, Lei Liu, J Kim Penberthy, Carlo C DiClemente, Ming D Li. Am J Psychiatry 2011
126
11



Alcoholism: the dissection for endophenotypes.
Lisa M Hines, Lara Ray, Kent Hutchison, Boris Tabakoff. Dialogues Clin Neurosci 2005
51
11


An 8-year follow-up of 450 sons of alcoholic and control subjects.
M A Schuckit, T L Smith. Arch Gen Psychiatry 1996
479
11

ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review.
Mimy Y Eng, Susan E Luczak, Tamara L Wall. Alcohol Res Health 2007
206
11

Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.
Lara A Ray, Spencer Bujarski, Pauline F Chin, Karen Miotto. Neuropsychopharmacology 2012
54
11

Research 2.0: social networking and direct-to-consumer (DTC) genomics.
Sandra Soo-Jin Lee, LaVera Crawley. Am J Bioeth 2009
44
11

Consumers' views of direct-to-consumer genetic information.
Colleen M McBride, Christopher H Wade, Kimberly A Kaphingst. Annu Rev Genomics Hum Genet 2010
55
11

Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.
Katherine M James, Clayton T Cowl, Jon C Tilburt, Pamela S Sinicrope, Marguerite E Robinson, Katrin R Frimannsdottir, Kristina Tiedje, Barbara A Koenig. Mayo Clin Proc 2011
29
11

Effect of direct-to-consumer genomewide profiling to assess disease risk.
Cinnamon S Bloss, Nicholas J Schork, Eric J Topol. N Engl J Med 2011
347
11

Direct-to-consumer personalized genomic testing.
Cinnamon S Bloss, Burcu F Darst, Eric J Topol, Nicholas J Schork. Hum Mol Genet 2011
60
11

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
Li-Shiun Chen, Timothy B Baker, Megan E Piper, Naomi Breslau, Dale S Cannon, Kimberly F Doheny, Stephanie M Gogarten, Eric O Johnson, Nancy L Saccone, Jen C Wang,[...]. Am J Psychiatry 2012
93
11

Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences.
Molly J Dingel, Katrina Karkazis, Barbara A Koenig. Soc Sci Q 2012
20
11



Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.
A G Schuller, M A King, J Zhang, E Bolan, Y X Pan, D J Morgan, A Chang, M E Czick, E M Unterwald, G W Pasternak,[...]. Nat Neurosci 1999
258
11

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.
Jennifer W Tidey, Peter M Monti, Damaris J Rohsenow, Chad J Gwaltney, Robert Miranda, John E McGeary, James MacKillop, Robert M Swift, David B Abrams, Saul Shiffman,[...]. Alcohol Clin Exp Res 2008
103
11


Naltrexone and coping skills therapy for alcohol dependence. A controlled study.
S S O'Malley, A J Jaffe, G Chang, R S Schottenfeld, R E Meyer, B Rounsaville. Arch Gen Psychiatry 1992
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.